Friedman H, Seckman C E, Schwartz J H, Lanza F L, Royer G L, Stubbs C M
Clinical Pharmacology Unit, The Upjohn Company, Kalamazoo, MI 49001.
J Clin Pharmacol. 1989 Jun;29(6):559-62. doi: 10.1002/j.1552-4604.1989.tb03382.x.
This 7-day, single blind, randomized endoscopic tolerance study compared daily doses of 100, 150 and 200 mg flurbiprofen with 2600 mg aspirin. After seven days the flurbiprofen 100 and 150 mg groups had significantly less gastric irritation than the flurbiprofen 200 mg and aspirin groups. Flurbiprofen showed a linear dose-response relationship with respect to gastric injury and serum drug levels. Four subjects each on aspirin and flurbiprofen with the most severe injuries continued on their medications plus cimetidine and antacids for four more weeks. Both drug groups showed clinical improvement in the gastroduodenal area. In conclusion, flurbiprofen and aspirin therapy can be tolerated in the presence of gastroduodenal irritation by concomitantly administering cimetidine and antacids.
这项为期7天的单盲随机内镜耐受性研究,将每日剂量为100、150和200毫克的氟比洛芬与2600毫克阿司匹林进行了比较。7天后,100毫克和150毫克氟比洛芬组的胃刺激明显少于200毫克氟比洛芬组和阿司匹林组。氟比洛芬在胃损伤和血清药物水平方面呈现出线性剂量反应关系。阿司匹林和氟比洛芬组中各有4名损伤最严重的受试者继续用药,并加用西咪替丁和抗酸剂,持续4周。两个药物组在胃十二指肠区域均显示出临床改善。总之,在胃十二指肠刺激存在的情况下,通过同时给予西咪替丁和抗酸剂,氟比洛芬和阿司匹林治疗是可以耐受的。